HOME >> MEDICINE >> NEWS
Work on cancer-killing compound nets FSU professor major grant

TALLAHASSEE, Fla.--Within a laboratory on the Florida State University campus, a chemist leads a team of researchers in a quest to develop synthetic versions of rare natural substances. If all goes well, the team's efforts could pay off in the form of the next generation of cancer-fighting drugs.

Such research often is a long, laborious process that can take years to generate results -- but is essential if breakthroughs in medicine, engineering and the sciences are to occur. In the FSU chemist's case, the state of Florida has acknowledged that the wait may well be worth it.

Gregory B. Dudley, an assistant professor in FSU's department of chemistry and biochemistry, recently was awarded a $450,000, three-year grant from the James & Esther King Biomedical Research Program, which is operated by the Florida Department of Health.

The program (www.floridabiomed.com) supports biomedical research on the prevention, diagnosis, treatments and cures for tobacco-related diseases, including cancer.

Dudley and his doctoral students are doing research on the synthesis of roseophilin, a naturally occurring compound produced by an obscure species of bacteria. Roseophilin (pronounced rose-ee-oh-FILL-in), which was first identified by Japanese researchers in 1992, is cytotoxic, meaning it kills cancer cells.

Public funding such as the King grant is essential if scientists are to continue to make progress in the ongoing battle against cancer and other diseases, Dudley said.

"The grant will allow us to engage in the kind of fundamental research that is needed to bring down the cost and increase the effectiveness of future pharmaceutical drugs," he said.

Dudley explained that the overall mission of his lab is to develop better access to synthetic versions of "biologically important" chemicals for which nature provides a limited supply. Typically, he said, he and his students choose a molecule that has shown interesting properties and
'"/>

Contact: Gregory B. Dudley
gdudley@chem.fsu.edu
850-644-2333
Florida State University
12-Oct-2005


Page: 1 2 3

Related medicine news :

1. Nanoparticles carry cancer-killing drugs into tumor cells
2. New oxidation methods streamline synthesis of important compounds
3. AMPAKINE compounds a new potential treatment for respiratory depression
4. Green tea compound suppresses factors causing cartilage, bone destruction in arthritis
5. Green tea compound may be a therapy for people with rheumatoid arthritis
6. Anti-dandruff compound may help fight epilepsy
7. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
8. Chromium 6: A killer compound with an improbable trigger
9. New compound shows promise in halting HIV spread
10. New imaging compound might see Alzheimers earlier
11. U of M researchers discover compounds to shrink tumors

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Work cancer killing compound nets FSU professor major grant

(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Addictions ... the courses for people to become Certified Alcohol and Substance Abuse Counselors. , "We ... CE-Classes.com . “There is an acute shortage of Alcohol and Drug Counselors nationwide. ...
(Date:7/29/2015)... Simpsonville, SC (PRWEB) , ... July 30, 2015 , ... ... Recently, the doctors decided to add massage therapy to the offerings in the clinic; ... of the spine. , Massage therapist Crystal Gaines has joined AlignLife of Simpsonville ...
(Date:7/29/2015)... ... ... According to data released today by the Centers for Medicare & Medicaid Services, ... $32.50, a figure far lower than was originally projected, the Pharmaceutical Care Management Association ... in American health care. By offering an abundance of competing choices in each region ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Avatar Solutions ... and Systems (CAHPS) for PQRS Survey. , The CAHPS for PQRS Survey ... practices of 100 or more eligible providers must participate or they will receive a ...
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... ... Convenient Healthcare and Pharmacy Collaborative for retail healthcare providers begins in Kissimmee, ... pharmacists, nurse practitioners and physician assistants can work together to expand access to ...
Breaking Medicine News(10 mins):Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 2Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 3Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 4
(Date:7/30/2015)... WARSAW, Ind., July 30, 2015 , Net ... from the prior year period and an increase of 5.7% ... the second quarter was $(0.91), and adjusted earnings per share ... period , Company updates guidance Zimmer ... results for the quarter ended June 30, 2015.  The Company ...
(Date:7/29/2015)... Ill. , July 30, 2015  Astellas ... ACTIVE study evaluating the efficacy and safety of ... CRESEMBA® (isavuconazonium sulfate), under development for adults with ... Results from the study demonstrated that the trial ... in overall treatment response in isavuconazole-treated patients at ...
(Date:7/29/2015)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce its ... on Wednesday, August 5, 2015, after the close of U.S.-based ... officer, will host a conference call to review the results ... (PT). The press release and a live ... a link that is posted on the home page and ...
Breaking Medicine Technology:Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3
Cached News: